Delivering Tamoxifen within Solid Lipid Nanoparticles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Delivering Tamoxifen within Solid Lipid Nanoparticles
The aim of this study was to prepare and characterize physiochemically and biologically tamoxifen-loaded SLNs to evaluate their effectiveness as a drug-delivery system to treat breast cancers.


Pharmaceutical Technology
Volume 35, Issue 4, pp. 74-79

References

1. G. Fontana et al., Drug Deliv. 12 (6), 385–392 (2005).

2. V.C. Jordan, Br. J. Pharmacol. 110 (2), 507–517 (1993).

3. E. Memisoglu-Bilensoy et al., J. Control. Release 104 (3), 489–496 (2005).

4. J.S. Chawla and M.M. Amiji, Int. J. Pharm. 249 (1–2), 127–138 (2002).

5. K. Jores et al., Pharm. Res. 22 (11), 1887–1897 (2005).

6. H. Yuan et al., Colloids Surf. B. Biointerfaces 61 (2), 132–137 (2007).

7. K. Westesen, H. Bunjes, and M.H.J. Koch, J. Control. Release 48 (2–3,), 223–236 (1997).

8. A.Z. Mühlen, C.Schwarz, and W.Mehnert, Eur. J. Pharm. Biopharm. 45 (2), 149–155 (1998).

9. M.A. Schubert and C.C. Müller-Goymann, Eur. J. Pharm. Biopharm. 61 (1–2), 77–86 (2005).

10. R. Lander et al., Biotechnology Progress 16 (1), 80–85 (2000).

11. A.A. Attama and C.C. Müller-Goymann, Int. J. Pharm. 334 (1–2), 179–189 (2007).

12. I. Mountasser, H. Fessi, and A.W. Coleman, Eur. J. Pharm. Biopharm. 54 (3), 281–284 (2002).

13. I. Brigger et al., Int. J. Pharm. 214 (1–2), 37–42 (2001).

14. F. Ikom, G.K. Hanna, and G.W. Schmid-Schmid, Lymphology 32 (3), 90–102 (1999).

15. D.Z. Hou et al., Biomater. 24 (10), 1781–1785 (2003).

16. H.L. Reddy et al., Pharm. Dev. Tech. 11 (2), 167–177 (2006).

17. H.L. Wong et al., J. Pharm. Sci. 93 (8), 1993–2008 (2004).

18. H. Yuan et al., Int. J. Pharm. 348 (1–2), 137–145 (2008).

19. A. Maschke et al., Eur. J. Pharm. Biopharm. 65 (2), 175–187 (2007).

20. S.A. Wissing, O. Kayser, and R.H. Müller, Adv. Drug Deliv. Rev. 56 (9), 1257–1272 (2004).

21. L. Serpe et al., Anticancer Drug 15 (5), 525–536 (2004).

Citation: When referring to this article, please cite it as "R.Abbasalipourkabir, .Salehzadeh, R.Abdullah, "Delivering Tamoxifen Within Solid Lipid Nanoparticles,"Pharmaceutical Technology 35 (4) 74-80 (2011)."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here